The ACCF/AHA writing committee to create the 2011 Guideline on the Management of
Patients With Extracranial Carotid and Vertebral Artery Disease (ECVD) conducted a …

Intracranial atherosclerosis is one of the most common causes of stroke worldwide and is
associated with a high risk of recurrent stroke. New therapeutic approaches to treat this high …

Background Vorapaxar is a new oral protease-activated–receptor 1 (PAR-1) antagonist that
inhibits thrombin-induced platelet activation. Methods In this multinational, double-blind …

Background Dual-antiplatelet therapy with aspirin and a thienopyridine is a cornerstone of
treatment to prevent thrombotic complications of acute coronary syndromes and …

The standing guideline writing committee along with the parent Task Force identified trials
and other key data through October 2011 that may impact guideline recommendations. On …

Recommendations about therapy for hypertension are here preceded by some
considerations on the strength of available evidence on the benefits associated with …

The aims of severe perioperative bleeding management are three-fold. First, preoperative
identification by anamesis and laboratory testing of those patients for whom the …

In patients with manifestations of cardiovascular disease, acetylsalicylic acid (popularly
known as aspirin) has been the mainstay of treatment for decades owing to its capacity to …

Management of carotid bifurcation stenosis is a cornerstone of stroke prevention and has
been the subject of extensive clinical investigation, including multiple controlled randomized …

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation
Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI …